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Abstract
Background: In-vivo cardiovascular magnetic resonance (CMR) diffusion tensor imaging (DTI) allows imaging of
alterations of cardiac fiber architecture in diseased hearts. Cardiac amyloidosis (CA) causes myocardial infiltration of
misfolded proteins with unknown consequences for myocardial microstructure. This study applied CMR DTI in CA
to assess microstructural alterations and their consequences for myocardial function compared to healthy controls.
Methods: Ten patients with CA (8 AL, 2 ATTR) and ten healthy controls were studied using a diffusion-weighed
second-order motion-compensated spin-echo sequence at 1.5 T. Additionally, left ventricular morphology, ejection
fraction, strain and native T1 values were obtained in all subjects. In CA patients, T1 mapping was repeated after
the administration of gadolinium for extracellular volume fraction (ECV) calculation. CMR DTI analysis was performed
to yield the scalar diffusion metrics mean diffusivity (MD) and fractional anisotropy (FA) as well as the characteristics
of myofiber orientation including helix, transverse and E2A sheet angle (HA, TA, E2A).
Results: MD and FA were found to be significantly different between CA patients and healthy controls (MD 1.77 ±
0.17 10− 3 vs 1.41 ± 0.07 10− 3 mm2/s, p < 0.001; FA 0.25 ± 0.04 vs 0.35 ± 0.03, p < 0.001). MD demonstrated an
excellent correlation with native T1 (r = 0.908, p < 0.001) while FA showed a significant correlation with ECV in the
CA population (r = − 0.851, p < 0.002). HA exhibited a more circumferential orientation of myofibers in CA patients,
in conjunction with a higher TA standard deviation and a higher absolute E2A sheet angle. The transmural HA
slope was found to be strongly correlated with the global longitudinal strain (r = 0.921, p < 0.001).
Conclusion: CMR DTI reveals significant alterations of scalar diffusion metrics in CA patients versus healthy controls.
Elevated MD and lower FA values indicate myocardial disarray with higher diffusion in CA that correlates well with
native T1 and ECV measures. In CA patients, CMR DTI showed pronounced circumferential orientation of the
myofibers, which may provide the rationale for the reduction of global longitudinal strain that occurs in amyloidosis
patients. Accordingly, CMR DTI captures specific features of amyloid infiltration, which provides a deeper
understanding of the microstructural consequences of CA.
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Introduction
Amyloidosis is a multi-system disease that is caused by
the synthesis and accumulation of unstable and mis-
folded proteins leading to a loss of normal tissue archi-
tecture and function [1]. While almost every organ can
be affected by amyloid deposition, the prognosis of pa-
tients is mainly determined by the occurrence and extent
of myocardial involvement [2–4]. There are various
types of amyloid that differ in the source and nature of
the misfolded precursor protein. Of those, light chain as-
sociated amyloidosis (AL) and transthyretin amyloid
amyloidosis (ATTR) are the two main types of amyloid-
osis that affect the heart. The infiltration of amyloid to
the heart leads to myocardial thickening and diastolic
dysfunction resulting in heart failure.
For the assessment of cardiac amyloidosis (CA), cardiac
imaging plays a fundamental role [5]. Besides myocardial
thickening, echocardiography often shows a reduction of
global longitudinal strain, which typically spares the apical
segments [6]. Non-invasive characterization of the myo-
cardial tissue of amyloidosis patients is the strength of car-
diovascular magnetic resonance (CMR). In particular, the
extent and distribution of late gadolinium enhancement
(LGE) has been shown to provide independent informa-
tion on outcome even after adjustment for known prog-
nostic factors [7]. CA is also an ideal application for newer
mapping techniques as it leads to excessively high T1- and
extracellular volume (ECV) [8, 9]. Notably, in AL CA pa-
tients, ECV is a proven predictor of mortality with an up
to four-fold increased likelihood of death for ECV > 0.45
over a median follow-up period of 23months [10]. Both
LGE and ECV, however, rely on the application of gado-
linium-based contrast agents (GBCA), which is often lim-
ited in amyloidosis patients due to severely reduced renal
function.
Recently, CMR diffusion tensor imaging (DTI) emerged
as a promising method for the determination of myocar-
dial fiber orientation [11–13] and tissue characterization
without the need for GBCA. It allows to investigate water
diffusion within the tissue and to derive additional scalar
metrics, such as mean diffusivity (MD) and fractional
anisotropy (FA) for the quantification of structural integ-
rity [14, 15]. Alterations of cardiac microstructure have
been described in patients with dilated cardiomyopathy
(DCM), myocardial infarction and hypertrophic cardiomy-
opathy (HCM) [16–18]. In CA, however, the effect of the
double harm resulting from the combination of amyloid
infiltration with direct cardio-toxicity of abnormal pro-
teins [19] on the myocardial structure and its potential
impact on diffusion properties is yet unknown.
The objective of this study was to determine the con-
sequences of amyloid infiltration on myocardial micro-
structure in-vivo using CMR DTI and to investigate
their effect on myocardial function. Scalar diffusion and
relaxation metrics (MD/FA and native T1/ECV, respect-
ively) were correlated in CA patients and controls. In
addition, directional diffusion information was assessed
to reveal changes in myofiber orientations and compared
to parameters of left ventricular (LV) function.
Methods
Study design
Between March 2017 and June 2018, 12 patients with AL
or ATTR CA (63 ± 11 years, 3 female), referred to the local
outpatient clinic, and 10 healthy, age-matched controls
(62 ± 11 years, 4 female) were prospectively enrolled. Ex-
clusion criteria were cardiovascular disease other than
CA, kidney failure with estimated glomerular filtration
rate (eGFR) < 30ml/min/1.76 m2 and the standard exclu-
sion criteria for CMR [20]. Height and weight of all study
subjects were recorded to calculate the body surface area
(BSA). All patients had histologically proven (positive
Congo red staining of endomyocardium, abdominal fat,
kidney, rectum or bone marrow biopsies) amyloidosis and
echocardiographic or CMR findings typical for cardiac
involvement. Imaging was performed on a clinical 1.5
T system (Achieva, Philips Healthcare, Best, The
Netherlands) equipped with a 5-channel cardiac re-
ceiver array. Prior to imaging, written informed con-
sent was obtained from all subjects. The study
protocol was approved by the ethics committee of the
canton of Zurich; it allowed the administration of
GBCA only in the CA patient group.
CMR data acquisition
Cardiac function was assessed by a contiguous stack of
balanced steady-state free precession (bSSFP) short-axis
cine images covering the entire LV and bSSFP long-axis
cine images in 2-chamber, 3-chamber and 4-chamber
orientations. According to the cine images, systolic qui-
escent time points were determined on a per subject
basis.
Diffusion-weighted imaging was performed with a sin-
gle-shot spin-echo sequence utilizing second-order mo-
tion compensated diffusion sensitizing gradients in
combination with an echo planar imaging (EPI) readout
[21, 22]. The sequence was electrocardiogram (ECG)-
triggered to mid-systole systole (65% of peak systole)
and three imaging planes were placed in short-axis view
orientation at apical, mid-ventricular and basal level LV
using a reduced field-of-view (FOV) technique [23]. Dif-
fusion weighting was encoded along nine and three
directions with a b-value of 450 and 100 s/mm2, respect-
ively [24]. Data acquisition was performed during free
breathing with respiratory navigator-based slice tracking
[25]. The imaging parameters are listed in Table 1.
T1 mapping was performed using a modified Look-
Locker inversion (MOLLI) sequence with a total of eight
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T1 weighted images split into a set of five and three
images acquired after inversion, separated by three
heartbeats of recovery (5-(3)-3 scheme) [26]. The im-
aging planes were at the same slice location as the DTI
scan. In all subjects, native T1 maps were acquired. For
ECV calculation, T1 mapping was repeated in the pa-
tient group 20min after a bolus injection of 0.2 mmol/kg
gadolinium-based contrast agent (Gadovist, Bayer
Schering, Berlin, Germany). The hematocrit was mea-
sured in all patients within 2 h of CMR. LGE images
were acquired with an inversion-recovery sequence
approximately 10 min after the bolus injection.
CMR data analysis
Standard measurements of LV size and function includ-
ing LV ejection fraction (LVEF), left ventricular mass
index (LVMi) and intraventricular septal wall thickness
(IVS) were obtained using the GTVolume software pack-
age (GyroTools LLC, Zurich, Switzerland). The LV end-
systolic global longitudinal strain (GLS) and global
circumferential strain (GCS) were calculated using a cer-
tified CMR feature tracking evaluation software (2 D
CPA MR, Cardiac Performance Analysis MR Version 4,
TomTec Imaging Systems, Unterschleissheim, Germany)
on the long- and short-axis bSSFP images.
Prior to diffusion tensor calculation and T1 fitting, the
individual MOLLI and DTI images were registered using
a non-rigid groupwise image registration method [27] for
compensation of residual motion. DTI analysis was per-
formed on MD, FA, helix angle (HA), transverse angle
(TA) and absolute E2A sheet angle [16, 28]. A detailed de-
scription of the DTI parameters is provided as Add-
itional file 1. For calculating the HA slope, a linear
regression of the transmural course of the helix angles be-
tween the endocardium and epicardium was performed,
excluding boundary pixels at the endo- and epicardium.
Angular diffusion metrics were evaluated in four radial
and circumferential sectors of the left ventricle and
averaged across all three slices. Mean LV signal-to-
noise ratio (SNR) of the b = 100 s/mm2 image was de-
termined in both patient groups for quality control.
The scalar diffusion metrics MD and FA as well as
native T1 and ECV, were evaluated in a single septal
region-of-interest (ROI) on the midventricular short-
axis slices in accordance with current clinical recom-
mendations [29]. ECV was computed based on the
collected haematocrit, native and enhanced T1 values
in the myocardium and the blood pool.
Statistical analysis
All data are expressed as mean ± SD. Statistical analysis
was conducted using MedCalc software (MedCalc 17.9.7,
MedCalc Software bvba, Ostend, Belgium). Differences in
diffusion and relaxation metrics between patients and
controls were assessed by unpaired two-tailed t-tests. To
determine statistical associations between parameters,
Pearson correlation analyses were performed. In addition,
the diagnostic accuracy of native T1, MD and FA for de-
tecting cardiac amyloidosis compared to healthy controls
was examined by ROC analysis. A p-value less than 0.05
was considered statistically significant.
Results
Patient characteristics
Data from two of 12 CA subjects were excluded, one for
difficulty with breath-holding and one for technical rea-
sons. Ten CA patients (60 ± 11 years, 7 male) were hence
included in the analysis. Eight patients suffered from AL-
amyloidosis while two had ATTR-amyloidosis (one wild
type, one heterozygous mutation c.238A >G). The diagno-
sis of CA was confirmed by endomyocardial biopsy (n = 4)
or the combination of typical imaging findings (echocardi-
ography or CMR) with proven amyloid deposition in bone
marrow (n = 3), kidney (n = 1), rectum (n = 1) or abdom-
inal fat (n = 1) biopsies. The renal function was normal in
two patients, while there were five patients with mildly
and three patients with moderately reduced renal function
(eGFR: 70 ± 21ml/min). The age- and sex-matched con-
trol group also showed similar BSA characteristics. The
IVS (14.4 ± 2.6 vs 8.0 ± 1.3mm, p < 0.001) and the LVMi
(79 ± 19 vs 44 ± 7 g/m2, p < 0.001) were significantly ele-
vated in CA patients. While GLS was significantly im-
paired in CA patients (− 16.6 ± 3.3 vs − 22.4 ± 1.9%, p <
0.001), GCS (− 26.9 ± 5.5 vs − 29.1 ± 3.1%, p = 0.30) and
LVEF (64 ± 6 vs 61 ± 4%, p = 0.20) exhibited no significant
difference between the groups. Table 2 contains the base-
line characteristics of both groups.
Comparison of scalar DTI parameters with ECV and native T1
Midventricular septal reference values, obtained in the
healthy controls were 1.41 ± 0.07 10− 3 mm2/s for MD,
0.35 ± 0.03 for FA and 1020 ± 42ms for native T1. In the
Table 1 CMR Scan Parameters
DTI T1 Mapping LGE
Spatial Resolution [mm3] 2.5 × 2.5 × 8 1.2 × 1.2 × 8 1.6 × 1.6 × 10
FOV [mm2] 230 × 105 300 × 300 360 × 460
TR 3 beats 2.5 ms 3.5 ms
TE [ms] 76 1 1.7
Flip Angle [°] 90 35 15
Number of Averages 12 1 1
Respiratory Mode Free Breathing Breath Hold Breath Hold
Approx. Scan Time [min.] 8–10min 1–2 min 1 min
DTI diffusion tensor imaging, FOV field of view, LGE late gadolinium
enhancement, TE echo time, TR repetition time
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CA group, a significantly higher native T1 (1136 ± 61ms,
p < 0.001), highly elevated MD (1.77 ± 0.17 10-3 mm2/s,
p < 0.001) and significantly reduced FA (0.25 ± 0.04, p <
0.001) were found when comparing with the healthy
control group. ECV in the CA group was elevated to
0.50 ± 0.14. Figure 1 depicts representative mid-ventricu-
lar slices of MD, FA and native T1 of a healthy control
and an AL-amyloidosis case with additional ECV and
LGE images in the CA patient. Comparing the different
modalities within the CA patient, it can be appreciated
that the areas of LGE hyperenhancement and elevated
ECV correspond well with the regions of high MD and
low FA in the parameter maps derived from DTI.
Direct comparison between native T1 values versus
MD over the whole study population demonstrates an
excellent correlation between the two parameters (r =
0.909, 95% CI [0.778, 0.963], p < 0.001, Fig. 2a). A
weaker, but still significant negative correlation was also
found between native T1 and FA (r = − 0.715, 95% CI [−
0.879, − 0.398]; p < 0.001; Fig. 2b). The analysis of correl-
ation between DTI-based parameters and ECV was lim-
ited to the CA group. It exhibited a fair correlation
between ECV and MD (r = 0.744, 95% CI [0.216, 0.936];
p = 0.014; Fig. 2c) and a strong negative correlation be-
tween ECV and FA (r = − 0.851, 95% CI [− 0.964, − 0.477];
p < 0.002; Fig. 2d).
For the differentiation between healthy controls and CA
patients, the scalar DTI parameters exhibit promising ac-
curacy with an area under the curve (AUC) of 0.96 [95%
CI, 0.77–1.00] for MD and 0.97 [95% CI, 0.78–1.00] for
FA which were not significantly different from the diag-
nostic performance of native T1 (AUC 0.91 [95% CI,
Table 2 Baseline characteristics of the Study Population
CA
Patients
N = 10
Healthy
Controls
N = 10
p-value
Age [years] 60 ± 11 62 ± 11 0.79
Male (%) 7 (70) 6 (60) 0.73
BSA [m2] 1.80 ± 0.13 1.85 ± 0.18 0.50
AL-Amyloidosis 8 (80)
ATTR-Amyloidosis 2 (20)
IVS [mm] 14.4 ± 2.6 8.0 ± 1.3 < 0.001
LVEDV [ml] 134 ± 25 133 ± 20 0.97
LVMi [g/m2] 79 ± 19 44 ± 7 < 0.001
LVEF [%] 64.0 ± 6.3 60.7 ± 3.9 0.20
GLS [%] −16.6 ± 3.3 −22.4 ± 1.9 < 0.001
GCS [%] −26.9 ± 5.5 −29.1 ± 3.1 0.30
Data are mean ± SD or number of patients (%)
AL amyloid light chain, ATTR transthyretin-associated amyloidosis, BSA body
surface area, CA cardiac amyloidosis, GCS global circumferential strain, GLS
global longitudinal strain, IVS interventricular septum thickness in diastole,
LVEDV left ventricular end-diastolic volume, LVEF left ventricular ejection
fraction, LVMi left ventricular mass indexed to body surface area
Fig. 1 Representative mean diffusivity (MD), fractional anisotropy (FA) and native T1 maps for a healthy control (a) and a light chain (AL) amyloidosis
patient (b). Enhanced T1 mapping, extracellular volume fraction (ECV) mapping and late gadolinium enhancement (LGE) CMR imaging was only
performed in the cardiac amyloid (CA) patient. It can be appreciated, that the areas of signal hyperenhancement in LGE and elevated ECV correspond
well with regions of high MD and low FA in the parameter maps derived from CMR diffusion tensor imaging (DTI) in the CA patient
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0.69–0.99]). Additional file 2: Figure S2 provides detailed
information on the AUC analysis (Additional file 2).
Evaluation of myocardial microstructure in cardiac
amyloidosis
Figure 3a depicts the comparison of the HA, TA and ab-
solute E2A sheet angle of a representative CA patient
and a healthy control. At first sight, despite the thicker
myocardium in CA patients, the distribution of HA
seems similar between both groups (Fig. 3a first row).
Quantitative evaluation, however, reveals that the trans-
mural HA slope is significantly reduced in CA patients
(− 0.83 ± 0.16 °/% transmural depth (tmd) vs − 1.02 ±
0.14 °/%tmd; p < 0.001). In case of the patients, this leads
to a reduced longitudinal orientation of fibers in the epi-
cardial and endocardial layers compared to the controls
as shown in the bullseye plots in Fig. 3b first row.
The TA is close to zero degrees in both groups with no
significant difference between CA patients and healthy
controls (4.5 ± 4.6 vs 2.5 ± 3.6°, p = 0.07). The standard de-
viation per segment, however, is significantly larger in the
CA patients (18.2 ± 6.6 vs 12.7 ± 2.6°, p < 0.001) indicating
a higher level of deviation from the circumferential align-
ment of the myocardial fibers found in healthy subject
myocardium. Representative TA maps are shown in Fig.
3a middle row. The higher TA standard deviation can be
appreciated by the more irregular appearance of the TA
map in the CA patient and the quantitative overview in
Fig. 3b middle row.
The most prominent difference in the myocardial
microstructure between CA patients and healthy controls
becomes evident in the comparison of the absolute E2A
sheet angle. Patients exhibited higher mean absolute E2A
sheet angles in every segment with values approximately
20° greater than those of healthy subjects (52.9 ± 7.5 vs
33.9 ± 9.5°, p < 0.001, Fig. 3ab lower row). Average SNR of
a single b = 100 s/mm2 image was comparable between
patients and controls (12.0 ± 3.0 vs 12.5 ± 3.6, p = 0.62).
Correlation between myocardial microstructure and left
ventricular function
HA slope and E2A sheet angle were correlated against
LVEF, GLS and GCS. A strong correlation was found
between HA slope and GLS (r = 0.921, 95% CI [0.809,
0.969]; p < 0.0001; Fig. 4a), indicating impaired longitu-
dinal function with a flatter transmural HA gradient. A
weaker, but still significant correlation could be observed
between E2A sheet angle and GLS (r = 0.763, 95% CI
[0.483, 0.901]; p = 0.0001; Fig. 4b). LVEF and GCS
Fig. 2 Correlation plots for MD and FA with native T1 and ECV. Native T1 shows an excellent correlation with MD (a) and a moderate but still
significant negative correlation with FA (b). Within the patient population, MD is also correlated with ECV (c) but FA exhibits a higher correlation
with ECV (d)
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exhibited no significant correlation with any parameter
describing the myocardial microstructure.
Discussion
This study assessed the value of cardiac DTI for the evalu-
ation of patients with CA and investigated the effects of
amyloid deposition on myocardial microstructure.
The scalar DTI metrics of MD and FA were found to
be significantly altered by CA. In comparison with native
T1, which was also elevated in CA patients in agreement
with previous studies [10, 30], MD and FA exhibited a
comparable AUC to identify CA patients indicating po-
tential for similar diagnostic accuracy. The correlation
between MD and native T1 suggests that the pathome-
chanism of amyloid infiltration affects both parameters
to a similar extent. While native T1 is a useful diagnostic
marker for CA, recent studies have shown that it is in-
ferior to ECV as an independent predictor of prognosis
in AL-amyloidosis as well as ATTR-amyloidosis patients
[30, 31]. However, the significant number of amyloidosis
patients suffering from renal failure stresses the need for
a gadolinium-free substitute for ECV with potential
prognostic value. The robust correlation between FA
and ECV found in the CA patients justifies expectations,
that FA may have potential to serve as such a substitute
for ECV. This warrants future trials to investigate the
diagnostic accuracy of FA and MD for amyloidosis in
particular against other cardiomyopathies with a HCM
phenotype. The existence of a tight functional relation
between FA and ECV is also suggestive from a
Fig. 4 Correlation plots for GLS with HA slope and E2A sheet angle. The HA slope shows an excellent correlation with GLS (a) while a moderate
but still significant correlation between GLS and E2A could be observed (b)
Fig. 3 Example helix angle (HA), transverse angle (TA) and sheet angle (E2A) map for a healthy control subject and an AL-amyloidosis patient (a).
Image (b) shows Bullseye plots for HA, TA and E2A across all subjects for each cohort. Reported values are mean ± SD
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microstructural perspective, since the scalar CMR DTI
parameters describe the range and anisotropy of myocar-
dial water movement, which is mainly determined by the
tissue-specific presence of spatially ordered cellular com-
partments within the myocardium [32]. Our findings are
supported by previous studies, which have demonstrated
that quantitative measures of diffusivity derived from
CMR DTI capture similar properties as LGE and ECV in
myocardial infarction and HCM [33, 34].
Time efficiency is an essential criterion for clinical
practice under the economic constraints of healthcare
systems. From this point of view, measurement dura-
tions of approximately ten minutes seem unreasonably
long and insufficient for daily routine in CMR imaging.
However, the presented sequence acquired three slices,
two of which, namely the basal and apical slice were only
used for the determination of myocardial microarchitec-
ture. The MD and FA values were only assessed in the
mid-ventricular slice as recommended in the current
consensus document [29]. Limiting the acquisition to a
single mid-ventricular slice would reduce the measure-
ment time by approximately 25% assuming a 1.5 T CMR
system and a heart rate of 60 beats per minute. In
addition, replacing LGE and ECV with DTI would also
eliminate the 10–15 min waiting period before LGE and
ECV [35, 36] imaging and could ultimately lead to a sav-
ing of time.
Our investigation of myocardial architecture provided
new insights into the microstructural alterations due to
interstitial amyloid deposition. The most prominent ob-
servation of significantly increased absolute E2A sheet
angle is the structural equivalent of a more systolic con-
formation of the myocardial sheetlets. The correlation
between E2A sheet angle and GLS may indicate that, at
a microstructural level, a pronounced systolic sheetlet
configuration might be associated with a limited ability
to rotate to a relaxed conformation in diastole. Similar
observations have been made in HCM patients [17], in-
dicating that despite fundamentally different pathogen-
esis, comparable structural alterations may cause the
primary diastolic heart failure observed in both diseases.
The difference in HA between health and disease, how-
ever, has not yet been described. The significantly lower
HA slope of CA patients results in a reduced transmural
HA gradient with a less longitudinal orientation of the
myocardial fibers. The strong correlation which we ob-
served between the HA slope and the GLS indicates, that
the more circumferential myofiber orientation may be
the microstructural determinant for the loss of longitu-
dinal function in amyloidosis patients. This finding
seems not to be a common feature of all hypertrophic
phenotype cardiomyopathies as Nielles-Vallespin et al.
described similar HA configuration in HCM patients
and healthy controls [17]. In agreement with the
hypothesis of the HA slope being a determinant for lon-
gitudinal function, a recent study by Pagourelias et al.
demonstrated that the GLS of CA patients is signifi-
cantly lower compared to HCM patients with identical
myocardial wall thickness [37]. In addition to the micro-
structural alterations, the direct cardio-toxicity of amyl-
oid deposition may also contribute to a loss of
myocardial function in CA patients [19].
It remains unclear whether the relation between HA
slope and GLS is linear over a wider range. A previous
study by von Deuster et al. [16] in DCM patients reported
similar HA slope in controls and patients with mildly re-
duced LVEF, but two patients with advanced heart failure
showed reduced GLS and increased HA slope. In synopsis,
these findings support the hypothesis of a U-shaped rela-
tion between HA slope and GLS with an ideal HA slope
around 1°/%tmd and impaired longitudinal function caused
by deviations to significantly higher and lower HA slope
values. The different constellations of DTI parameters ob-
served in HCM, DCM and amyloidosis raise the hope that
future research may identify disease specific patterns of
DTI parameters, which would be an advantage over rather
unspecific parameters such as native T1 that is elevated in
a multitude of cardiac diseases. The presence of subtype
specific patterns of the DTI parameters for AL- and
ATTR-amyloidosis should be investigated, in particular in
comparison to nuclear imaging techniques where radio-
tracers used for technetium-labeled bone scintigraphy are
found to have high sensitivity for ATTR [38], while 18F-
florbetaben-PET has recently been shown to have a high
sensitivity for AL-amyloidosis [39].
In contrast to HA and E2A, the transverse angle does
not seem to provide relevant insights into disease spe-
cific pathologies as it is distributed around 0° in health
and disease. However, the elevated standard deviation of
TA that we observed in amyloidosis patients has previ-
ously already been observed in DCM patients [16] and
may therefore be a surrogate for myocyte disarray of any
cause. A bias of the TA distribution due to low SNR,
which has been observed in previous studies [24], could
be excluded in our work since SNR values were not dif-
ferent between the amyloidosis and control cohorts.
Limitations
A limitation of the present work is the small sample size
of CA patients with different types of the disease. In par-
ticular the patient number is insufficient to investigate
potential effects of the different pathophysiologies of
AL- and ATTR-amyloidosis on the myocardial micro-
structure. In addition, the lack of GBCA application in
healthy controls, due to constraints from ethical ap-
proval constitutes a limitation. However, despite those
limitations, our patient population already showed
promising diagnostic properties of CMR DTI based
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parameters warranting future research in a larger popu-
lation of CA patients. In contrast to previous studies
using STEAM based DTI methods [40], this study was
limited to investigate the mid-systolic configuration of
the myocardium and did not assess a diastolic state.
Conclusion
The scalar CMR DTI parameters MD and FA in CA pa-
tients are significantly different from healthy controls,
allowing to assess the amyloid induced microstructural
disarray without the use of GBCA. The major differences
in myofiber orientation are a significantly increased E2A
sheet angle and a reduced HA slope in CA patients. Fi-
nally, the strong correlation between HA slope and GLS
indicates, that the more circumferential orientation of
the myofibers may provide the rationale for the reduc-
tion of CLS that occurs in CA.
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